sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Pharmaceuticals / Active Pharmaceutical Ingredient

Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

  • Publish On: Apr-2021
  • Total Pages: 225
  • Report Code: FAF-1420
  • Base Year: 2020
  • Format:

Industry Insights

[225+ Pages Report] Global Active Pharmaceutical Ingredient market was valued at USD 177.6 billion in 2019, which is anticipated to hit USD 258.3 billion by 2026 with an expected CAGR of 5.5% between 2020 and 2026.

Global Active Pharmaceutical Ingredient Market: Overview

API is synthetically and organically complex components of medicines with a clear effect on disease cure, moderation, therapy, and counter activity. Over the past few decades, the worldwide API industry has seen tremendous growth due to the increased use of drugs and biologics in disease management. The increasing appropriation of value models for API production, such as Good Manufacturing Practices (GMP), existing GMPs (cGMP) has improved the safety guidelines. On the other hand, the API sector faces the challenges of, for example, shortening the improvement process, reducing the cost of progress, strengthening the procedural framework, and complying with consistency guidelines without taking advantage of them.

Global Active Pharmaceutical Ingredient Market: Growth Factor

The growing activity for research and development on drug production increased popularity of generic products, and the use of biopharmaceuticals, are the key factors driving the growth of the global active pharmaceutical industry. The unfavorable policies of price regulation for drugs in different countries and high production costs are, however, likely to hamper demand growth.

The growing prevalence of chronic diseases would raise the demand for medicines, which is projected to accelerate the market growth of active pharmaceutical ingredients in the immediate future. The world's leading cause of death was cardiovascular diseases, estimating about 17.9 million lives a year, according to the WHO.

Around 5.8 million people in the U.S. were reported to suffer from Alzheimer's in 2018 by the Alzheimer's Association. The illness is the sixth most common cause of death for people over 65 years of age in the United States. The population of baby booms is estimated to reach 14 million and to intensify in the projected timeframe, approaching the age of about 65. By 2050, every 33 seconds a new case of this disease could arise. ?

In addition, the sales, acquisitions, cooperation, and international expansions of new drugs and biological products are some of the competitive market stabilization measures. In the near term, this will contribute to demand growth. In 2020, for example, Quartic.ai and Bright Path Laboratories worked together to create AI-based technologies to produce vital APIs, which are expected to produce essential small molecular medicines.

Drugs such as anti-infective and diabetes, cardiovascular, analgesics, and pain relief medicines historically occupied the Active Pharmaceutical Ingredients (API) industry. However, the market for complex APIs used in new formulations, targeting niche clinical areas, is changing according to R&D patterns.

Active Pharmaceutical Ingredient Market: COVID-19 Impact

The COVID-19 pandemic in 2020 produced a positive market effect, as the countries and key players produce large volumes of ingredients to keep demands for COVID 19 medication. COVID-19 has resulted in pharmaceutical companies reorienting their models to a wider population of customers. For instance, the US has requested that coronavirus treatments be imported from India for hydroxychloroquine (HCQ). The virus has already interrupted Canada's supply chain and may cause patients in the country problems. Canadian pharmaceutical supervisors are expanding their services to new areas of countries other than China.

Global Active Pharmaceutical Ingredient Market: Regional Analysis

In 2020, North America was the biggest market share of 39.5% and its lead over the projected horizon is anticipated to continue. This is due to the increased cancer epidemiology, as well as other lifestyle disorders, and hence encourages research and development programs to fuel business growth.

In the forecast timeframe, Asia Pacific is expected to show the fastest CAGR. The area is benefitted from the existence of economies such as China and India, on which the world depends on low-cost API processing. The region is expected to improve demand growth by rising healthcare spending.

Over the projected period, Europe is expected to see considerable growth. There is an expectation that increased research spending and the local involvement of major industry players in the area would propel the market. As a result of increased funding, the number of biopharmaceutical companies in Europe is rising.

Global Active Pharmaceutical Ingredient Market: Competitive Players

There are great complexities in the market of active pharmaceutical ingredients. Blockbuster drugs are likely to continue to compete highly over the projected timeframe, owing to the expiry of the patent, rising outsourcing practices due to high manufacturing costs, and strict production regulations for APIs.

Many key figures are subject to legal investigation due to non-compliance. For example, in August 2019, the United States FDA released 75 API manufacturing plants alarm letters, half of whom were for Indian and Chinese companies. Such rigorous legislation can serve as a limiting factor in the development of the industry. Furthermore, the development of new API facilities is slowing down legal problems. For eg, the U.S.FDA faced problems with the API plants of Dr. Reddy Laboratories and Eli Lilly and the company in 2020.

Some prominent players in the global active pharmaceutical ingredients market are Cipla, Bristol Myers Squibb, Boehringer Ingelheim GmbH, BASF SE, Aurobindo Pharma, Albemarle Corporation, Abbvie Inc., Dr. Reddy’s Laboratories Ltd, Eli Lilly and Company, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc., Novartis AG, Mylan NV, Merck & Co., and Lupin Ltd among others.

Global Active Pharmaceutical Ingredient Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • The Middle East and Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Active Pharmaceutical Ingredients
    2. 1.2. Global Active Pharmaceutical Ingredients Market, 2019 & 2026 (USD Million)
    3. 1.3. Global Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 1.4. Global Active Pharmaceutical Ingredients Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global Active Pharmaceutical Ingredients Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 Active Pharmaceutical Ingredients Market – Type Analysis
    1. 2.1. Global Active Pharmaceutical Ingredients Market – Type Overview
    2. 2.2. Global Active Pharmaceutical Ingredients Market Share, by Type, 2019 & 2026 (USD Million)
    3. 2.3. Innovative APIs
      1. 2.3.1. Global Innovative APIs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 2.4. Generic APIs
      1. 2.4.1. Global Generic APIs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Active Pharmaceutical Ingredients Market – Manufacturer Analysis
    1. 3.1. Global Active Pharmaceutical Ingredients Market – Manufacturer Overview
    2. 3.2. Global Active Pharmaceutical Ingredients Market Share, by Manufacturer, 2019 & 2026 (USD Million)
    3. 3.3. Captive Manufacturers
      1. 3.3.1. Global Captive Manufacturers Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 3.4. Merchant Manufacturers
      1. 3.4.1. Global Merchant Manufacturers Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Active Pharmaceutical Ingredients Market – Type of Synthesis Analysis
    1. 4.1. Global Active Pharmaceutical Ingredients Market – Type of Synthesis Overview
    2. 4.2. Global Active Pharmaceutical Ingredients Market Share, by Type of Synthesis, 2019 & 2026 (USD Million)
    3. 4.3. Synthetic
      1. 4.3.1. Global Synthetic Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 4.4. Biotech
      1. 4.4.1. Global Biotech Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
  5. Chapter 5 Active Pharmaceutical Ingredients Market – Drug Type Analysis
    1. 5.1. Global Active Pharmaceutical Ingredients Market – Drug Type Overview
    2. 5.2. Global Active Pharmaceutical Ingredients Market Share, by Drug Type, 2019 & 2026 (USD Million)
    3. 5.3. Prescription Drugs
      1. 5.3.1. Global Prescription Drugs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 5.4. Over-the-counter Drugs
      1. 5.4.1. Global Over-the-counter Drugs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
  6. Chapter 6 Active Pharmaceutical Ingredients Market – Therapeutic Application Analysis
    1. 6.1. Global Active Pharmaceutical Ingredients Market – Therapeutic Application Overview
    2. 6.2. Global Active Pharmaceutical Ingredients Market Share, by Therapeutic Application, 2019 & 2026 (USD Million)
    3. 6.3. Communicable Diseases
      1. 6.3.1. Global Communicable Diseases Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    4. 6.4. Oncology
      1. 6.4.1. Global Oncology Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    5. 6.5. Diabetes
      1. 6.5.1. Global Diabetes Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    6. 6.6. Cardiovascular Disease
      1. 6.6.1. Global Cardiovascular Disease Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    7. 6.7. Pain management
      1. 6.7.1. Global Pain management Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    8. 6.8. Respiratory Diseases
      1. 6.8.1. Global Respiratory Diseases Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
    9. 6.9. Others
      1. 6.9.1. Global Others Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
  7. Chapter 7 Active Pharmaceutical Ingredients Market – Regional Analysis
    1. 7.1. Global Active Pharmaceutical Ingredients Market Regional Overview
    2. 7.2. Global Active Pharmaceutical Ingredients Market Share, by Region, 2019 & 2026 (USD Million)
    3. 7.3. North America
      1. 7.3.1. North America Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      2. 7.3.2. North America Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026
      3. 7.3.3. North America Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026
      4. 7.3.4. North America Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026
      5. 7.3.5. North America Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026
      6. 7.3.6. North America Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026
      7. 7.3.7. U.S.
      8. 7.3.8. Canada
    4. 7.4. Europe
      1. 7.4.1. Europe Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      2. 7.4.2. Europe Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026
      3. 7.4.3. Europe Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026
      4. 7.4.4. Europe Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026
      5. 7.4.5. Europe Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026
      6. 7.4.6. Europe Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026
      7. 7.4.7. Germany
      8. 7.4.8. France
      9. 7.4.9. U.K.
      10. 7.4.10. Italy
      11. 7.4.11. Spain
      12. 7.4.12. Rest of Europe
    5. 7.5. Asia Pacific
      1. 7.5.1. Asia Pacific Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      2. 7.5.2. Asia Pacific Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026
      3. 7.5.3. Asia Pacific Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026
      4. 7.5.4. Asia Pacific Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026
      5. 7.5.5. Asia Pacific Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026
      6. 7.5.6. Asia Pacific Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026
      7. 7.5.7. China
      8. 7.5.8. Japan
      9. 7.5.9. India
      10. 7.5.10. South Korea
      11. 7.5.11. South-East Asia
      12. 7.5.12. Rest of Asia Pacific
    6. 7.6. Latin America
      1. 7.6.1. Latin America Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      2. 7.6.2. Latin America Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026
      3. 7.6.3. Latin America Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026
      4. 7.6.4. Latin America Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026
      5. 7.6.5. Latin America Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026
      6. 7.6.6. Latin America Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026
      7. 7.6.7. Brazil
      8. 7.6.8. Mexico
      9. 7.6.9. Rest of Latin America
    7. 7.7. The Middle-East and Africa
      1. 7.7.1. The Middle-East and Africa Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      2. 7.7.2. The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026
      3. 7.7.3. The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026
      4. 7.7.4. The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026
      5. 7.7.5. The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026
      6. 7.7.6. The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026
      7. 7.7.7. GCC Countries
      8. 7.7.8. South Africa
      9. 7.7.9. Rest of Middle-East Africa
  8. Chapter 8 Active Pharmaceutical Ingredients Market – Competitive Landscape
    1. 8.1. Competitor Market Share – Revenue
    2. 8.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 8.3. Strategic Developments
      1. 8.3.1. Acquisitions and Mergers
      2. 8.3.2. New Products
      3. 8.3.3. Research & Development Activities
  9. Chapter 9 Company Profiles
    1. 9.1. Abbvie Inc.
      1. 9.1.1. Company Overview
      2. 9.1.2. Product/Service Portfolio
      3. 9.1.3. Abbvie Inc. Sales, Revenue, and Gross Margin
      4. 9.1.4. Abbvie Inc. Revenue and Growth Rate
      5. 9.1.5. Abbvie Inc. Market Share
      6. 9.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 9.2. Albemarle Corporation
      1. 9.2.1. Company Overview
      2. 9.2.2. Product/Service Portfolio
      3. 9.2.3. Albemarle Corporation Sales, Revenue, and Gross Margin
      4. 9.2.4. Albemarle Corporation Revenue and Growth Rate
      5. 9.2.5. Albemarle Corporation Market Share
      6. 9.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 9.3. Aurobindo Pharma
      1. 9.3.1. Company Overview
      2. 9.3.2. Product/Service Portfolio
      3. 9.3.3. Aurobindo Pharma Sales, Revenue, and Gross Margin
      4. 9.3.4. Aurobindo Pharma Revenue and Growth Rate
      5. 9.3.5. Aurobindo Pharma Market Share
      6. 9.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 9.4. BASF SE
      1. 9.4.1. Company Overview
      2. 9.4.2. Product/Service Portfolio
      3. 9.4.3. BASF SE Sales, Revenue, and Gross Margin
      4. 9.4.4. BASF SE Revenue and Growth Rate
      5. 9.4.5. BASF SE Market Share
      6. 9.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 9.5. Boehringer Ingelheim GmbH
      1. 9.5.1. Company Overview
      2. 9.5.2. Product/Service Portfolio
      3. 9.5.3. Boehringer Ingelheim GmbH Sales, Revenue, and Gross Margin
      4. 9.5.4. Boehringer Ingelheim GmbH Revenue and Growth Rate
      5. 9.5.5. Boehringer Ingelheim GmbH Market Share
      6. 9.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 9.6. Bristol Myers Squibb
      1. 9.6.1. Company Overview
      2. 9.6.2. Product/Service Portfolio
      3. 9.6.3. Bristol Myers Squibb Sales, Revenue, and Gross Margin
      4. 9.6.4. Bristol Myers Squibb Revenue and Growth Rate
      5. 9.6.5. Bristol Myers Squibb Market Share
      6. 9.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 9.7. Cipla
      1. 9.7.1. Company Overview
      2. 9.7.2. Product/Service Portfolio
      3. 9.7.3. Cipla Sales, Revenue, and Gross Margin
      4. 9.7.4. Cipla Revenue and Growth Rate
      5. 9.7.5. Cipla Market Share
      6. 9.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
      7. 9.8. Dr. Reddy’s Laboratories Ltd
      8. 9.8.1. Company Overview
      9. 9.8.2. Product/Service Portfolio
        1. 9.8.3. Dr. Reddy’s Laboratories Ltd Sales, Revenue, and Gross Margin
        2. 9.8.4. Dr. Reddy’s Laboratories Ltd Revenue and Growth Rate
        3. 9.8.5. Dr. Reddy’s Laboratories Ltd Market Share
      10. 9.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 9.9. Eli Lilly and Company
      1. 9.9.1. Company Overview
      2. 9.9.2. Product/Service Portfolio
      3. 9.9.3. Eli Lilly and Company Sales, Revenue, and Gross Margin
      4. 9.9.4. Eli Lilly and Company Revenue and Growth Rate
      5. 9.9.5. Eli Lilly and Company Market Share
      6. 9.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 9.10. Lupin Ltd
      1. 9.10.1. Company Overview
      2. 9.10.2. Product/Service Portfolio
      3. 9.10.3. Lupin Ltd Sales, Revenue, and Gross Margin
      4. 9.10.4. Lupin Ltd Revenue and Growth Rate
      5. 9.10.5. Lupin Ltd Market Share
      6. 9.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 9.11. Merck & Co.,
      1. 9.11.1. Company Overview
      2. 9.11.2. Product/Service Portfolio
      3. 9.11.3. Merck & Co., Sales, Revenue, and Gross Margin
      4. 9.11.4. Merck & Co., Revenue and Growth Rate
      5. 9.11.5. Merck & Co., Market Share
      6. 9.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 9.12. Mylan NV
      1. 9.12.1. Company Overview
      2. 9.12.2. Product/Service Portfolio
      3. 9.12.3. Mylan NV Sales, Revenue, and Gross Margin
      4. 9.12.4. Mylan NV Revenue and Growth Rate
      5. 9.12.5. Mylan NV Market Share
      6. 9.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 9.13. Novartis AG
      1. 9.13.1. Company Overview
      2. 9.13.2. Product/Service Portfolio
      3. 9.13.3. Novartis AG Sales, Revenue, and Gross Margin
      4. 9.13.4. Novartis AG Revenue and Growth Rate
      5. 9.13.5. Novartis AG Market Share
      6. 9.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 9.14. Pfizer Inc.
      1. 9.14.1. Company Overview
      2. 9.14.2. Product/Service Portfolio
      3. 9.14.3. Pfizer Inc. Sales, Revenue, and Gross Margin
      4. 9.14.4. Pfizer Inc. Revenue and Growth Rate
      5. 9.14.5. Pfizer Inc. Market Share
      6. 9.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 9.15. Sanofi
      1. 9.15.1. Company Overview
      2. 9.15.2. Product/Service Portfolio
      3. 9.15.3. Sanofi Sales, Revenue, and Gross Margin
      4. 9.15.4. Sanofi Revenue and Growth Rate
      5. 9.15.5. Sanofi Market Share
      6. 9.15.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 9.16. Sun Pharmaceutical Industries Ltd
      1. 9.16.1. Company Overview
      2. 9.16.2. Product/Service Portfolio
      3. 9.16.3. Sun Pharmaceutical Industries Ltd Sales, Revenue, and Gross Margin
      4. 9.16.4. Sun Pharmaceutical Industries Ltd Revenue and Growth Rate
      5. 9.16.5. Sun Pharmaceutical Industries Ltd Market Share
      6. 9.16.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    16. 9.17. Teva Pharmaceutical Industries Ltd
      1. 9.17.1. Company Overview
      2. 9.17.2. Product/Service Portfolio
      3. 9.17.3. Teva Pharmaceutical Industries Ltd Sales, Revenue, and Gross Margin
      4. 9.17.4. Teva Pharmaceutical Industries Ltd Revenue and Growth Rate
      5. 9.17.5. Teva Pharmaceutical Industries Ltd Market Share
      6. 9.17.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    17. 9.18. Viatris Inc
      1. 9.18.1. Company Overview
      2. 9.18.2. Product/Service Portfolio
      3. 9.18.3. Viatris Inc Sales, Revenue, and Gross Margin
      4. 9.18.4. Viatris Inc Revenue and Growth Rate
      5. 9.18.5. Viatris Inc Market Share
      6. 9.18.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  10. Chapter 10 Active Pharmaceutical Ingredients — Industry Analysis
    1. 10.1. Introduction and Taxonomy
    2. 10.2. Active Pharmaceutical Ingredients Market – Key Trends
      1. 10.2.1. Market Drivers
      2. 10.2.2. Market Restraints
      3. 10.2.3. Market Opportunities
    3. 10.3. Value Chain Analysis
    4. 10.4. Key Mandates and Regulations
    5. 10.5. Technology Roadmap and Timeline
    6. 10.6. Active Pharmaceutical Ingredients Market – Attractiveness Analysis
      1. 10.6.1. By Type
      2. 10.6.2. By Manufacturer
      3. 10.6.3. By Type of Synthesis
      4. 10.6.4. By Drug Type
      5. 10.6.5. By Therapeutic Application
      6. 10.6.6. By Region
  11. Chapter 11 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 11.1. Active Pharmaceutical Ingredients Industrial Chain Analysis
    2. 11.2. Downstream Buyers
    3. 11.3. Distributors/Traders List
  12. Chapter 12 Marketing Strategy Analysis
    1. 12.1. Marketing Channel
    2. 12.2. Direct Marketing
    3. 12.3. Indirect Marketing
    4. 12.4. Marketing Channel Development Trends
    5. 12.5. Economic/Political Environmental Change
  13. Chapter 13 Report Conclusion & Key Insights
    1. 13.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 13.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  14. Chapter 14 Research Approach & Methodology
    1. 14.1. Report Description
    2. 14.2. Research Scope
    3. 14.3. Research Methodology
      1. 14.3.1. Secondary Research
      2. 14.3.2. Primary Research
      3. 14.3.3. Statistical Models
      4. 14.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Active Pharmaceutical Ingredients
      Fig.2	COVID-19 Impacts on Active Pharmaceutical Ingredients Market
      Fig.3	Business Strategies and Recommendations
      Fig.4	Global Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.5	Global Active Pharmaceutical Ingredients Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.6	Global Active Pharmaceutical Ingredients Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.7	Global Active Pharmaceutical Ingredients Market Share, by Type, 2019 & 2026 (USD Million)
      Fig.8	Global Innovative APIs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.9	Global Generic APIs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.10	Global Active Pharmaceutical Ingredients Market Share, by Manufacturer, 2019 & 2026 (USD Million)
      Fig.11	Global Captive Manufacturers Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.12	Global Merchant Manufacturers Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.13	Global Active Pharmaceutical Ingredients Market Share, by Type of Synthesis, 2019 & 2026 (USD Million)
      Fig.14	Global Synthetic Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.15	Global Biotech Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.16	Global Active Pharmaceutical Ingredients Market Share, by Drug Type, 2019 & 2026 (USD Million)
      Fig.17	Global Prescription Drugs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.18	Global Over-the-counter Drugs Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.19	Global Active Pharmaceutical Ingredients Market Share, by Therapeutic Application, 2019 & 2026 (USD Million)
      Fig.20	Global Communicable Diseases Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.21	Global Oncology Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.22	Global Diabetes Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.23	Global Cardiovascular Disease Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.24	Global Pain management Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.25	Global Respiratory Diseases Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.26	Global Others Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.27	Global Active Pharmaceutical Ingredients Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.28	North America Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.29	U.S. Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.30	Canada Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.31	Europe Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.32	Germany Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.33	France Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.34	U.K. Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.35	Italy Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.36	Spain Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.37	Rest of Europe Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.38	Asia Pacific Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.39	China Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.40	Japan Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.41	India Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.42	South Korea Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.43	South-East Asia Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.44	Rest of Asia Pacific Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.45	Latin America Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.46	Brazil Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.47	Mexico Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.48	Rest of Latin America Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.49	The Middle-East and Africa Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.50	GCC Countries Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.51	South Africa Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.52	Rest of Middle-East Africa Active Pharmaceutical Ingredients Market, 2016 – 2026 (USD Million)
      Fig.53	Competitor Market Share – Revenue
      Fig.54	Abbvie Inc. Revenue and Growth Rate
      Fig.55	Abbvie Inc. Market Share
      Fig.56	Albemarle Corporation Revenue and Growth Rate
      Fig.57	Albemarle Corporation Market Share
      Fig.58	Aurobindo Pharma Revenue and Growth Rate
      Fig.59	Aurobindo Pharma Market Share
      Fig.60	BASF SE Revenue and Growth Rate
      Fig.61	BASF SE Market Share
      Fig.62	Boehringer Ingelheim GmbH Revenue and Growth Rate
      Fig.63	Boehringer Ingelheim GmbH Market Share
      Fig.64	Bristol Myers Squibb Revenue and Growth Rate
      Fig.65	Bristol Myers Squibb Market Share
      Fig.66	Cipla Revenue and Growth Rate
      Fig.67	Cipla Market Share
      Fig.68	Dr. Reddy’s Laboratories Ltd Revenue and Growth Rate
      Fig.69	Dr. Reddy’s Laboratories Ltd Market Share
      Fig.70	Eli Lilly and Company Revenue and Growth Rate
      Fig.71	Eli Lilly and Company Market Share
      Fig.72	Lupin Ltd Revenue and Growth Rate
      Fig.73	Lupin Ltd Market Share
      Fig.74	Merck & Co., Revenue and Growth Rate
      Fig.75	Merck & Co., Market Share
      Fig.76	Mylan NV Revenue and Growth Rate
      Fig.77	Mylan NV Market Share
      Fig.78	Novartis AG Revenue and Growth Rate
      Fig.79	Novartis AG Market Share
      Fig.80	Pfizer Inc. Revenue and Growth Rate
      Fig.81	Pfizer Inc. Market Share
      Fig.82	Sanofi Revenue and Growth Rate
      Fig.83	Sanofi Market Share
      Fig.84	Sun Pharmaceutical Industries Ltd Revenue and Growth Rate
      Fig.85	Sun Pharmaceutical Industries Ltd Market Share
      Fig.86	Teva Pharmaceutical Industries Ltd Revenue and Growth Rate
      Fig.87	Teva Pharmaceutical Industries Ltd Market Share
      Fig.88	Viatris Inc Revenue and Growth Rate
      Fig.89	Viatris Inc Market Share
      Fig.90	Market Dynamics
      Fig.91	Global Active Pharmaceutical Ingredients – Value Chain Analysis
      Fig.92	Key Mandates and Regulations
      Fig.93	Technology Roadmap and Timeline
      Fig.94	Market Attractiveness Analysis – By Type
      Fig.95	Market Attractiveness Analysis – By Manufacturer
      Fig.96	Market Attractiveness Analysis – By Type of Synthesis
      Fig.97	Market Attractiveness Analysis – By Drug Type
      Fig.98	Market Attractiveness Analysis – By Therapeutic Application
      Fig.99	Market Attractiveness Analysis – By Region
      Fig.100	Active Pharmaceutical Ingredients Industrial Chain Analysis
      Fig.101	Market Channels
      Fig.102	Marketing Channel Development Trend
      Fig.103	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global Active Pharmaceutical Ingredients Market, 2019 & 2026 (USD Million)
      Table 2	Global Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 3	Global Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 4	Global Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 5	Global Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 6	Global Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 7	Global Active Pharmaceutical Ingredients Market, by Region, 2016 – 2026 (USD Million)
      Table 8	North America Active Pharmaceutical Ingredients Market, by Country, 2016 – 2026 (USD Million)
      Table 9	North America Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 10 North America Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 11 North America Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 12 North America Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 13 North America Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 14 Europe Active Pharmaceutical Ingredients Market, by Country, 2016 – 2026 (USD Million)
      Table 15 Europe Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 16 Europe Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 17 Europe Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 18 Europe Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 19 Europe Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 20 Asia Pacific Active Pharmaceutical Ingredients Market, by Country, 2016 – 2026 (USD Million)
      Table 21 Asia Pacific Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 22 Asia Pacific Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 23 Asia Pacific Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 24 Asia Pacific Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 25 Asia Pacific Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 26 Latin America Active Pharmaceutical Ingredients Market, by Country, 2016 – 2026 (USD Million)
      Table 27 Latin America Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 28 Latin America Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 29 Latin America Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 30 Latin America Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 31 Latin America Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 32 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Country, 2016 – 2026 (USD Million)
      Table 33 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type, 2016 – 2026 (USD Million)
      Table 34 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Manufacturer, 2016 – 2026 (USD Million)
      Table 35 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2016 – 2026 (USD Million)
      Table 36 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 37 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2016 – 2026 (USD Million)
      Table 38 Global Active Pharmaceutical Ingredients Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 39 Global Active Pharmaceutical Ingredients Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 40 Acquisitions and Mergers
      Table 41 Market Drivers – Impact Analysis
      Table 42 Market Restraints
      Table 43 Market Opportunities
      Table 44 Major Buyers of Active Pharmaceutical Ingredients
      Table 45 Distributors/Traders of Active Pharmaceutical Ingredients by Region
      

Industry Major Market Players

  • Cipla
  • Bristol Myers Squibb
  • Boehringer Ingelheim GmbH
  • BASF SE
  • Aurobindo Pharma
  • Albemarle Corporation
  • Abbvie Inc.
  • Dr. Reddy’s Laboratories Ltd
  • Eli Lilly and Company
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Merck & Co.
  • Lupin Ltd 

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions